Search

everythinglearnresearchcommunity

for

Search:↓

The hHa7 gene is regulated by androgens in certain body hair, not scalp hair.

Silencing SFRP1 alone promotes hair growth, but adding DKK1 does not help.

Changes in testosterone and estrogen receptor genes can affect how men age, influencing body fat, hair patterns, and possibly leading to skin disorders.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

Minoxidil can reduce functions related to androgen receptors.

The human type II 5α-reductase gene has a specific structure important for understanding certain medical conditions.

TMPRSS2 is crucial for COVID-19 infection and is a potential target for treatment.

Sex hormones may be linked to inflammation in Hidradenitis Suppurativa.

Minoxidil may work for hair loss by reducing androgen sensitivity and altering hormone-related enzymes.

Androgen receptors help prostate cancer cells grow and resist drugs.

The study found that androgen receptors in skin cells mainly affect the focal adhesion pathway and control the caveolin-1 gene, with implications for new treatments for related diseases.

Androgen receptors play a key role in male development and prostate cancer, with treatments targeting androgen action.

The ABI1 gene contributes to prostate cancer progression and treatment resistance.

Key enzymes control androgen levels, affecting hormone activity and potential treatments.

ERG increases SOX9, promoting prostate cancer growth and invasion.

Research from 2011 to 2020 shows androgen receptors could be key for prognosis and treatment in certain breast cancers.

The conclusion is that androgenetic alopecia and senescent alopecia have unique gene changes, suggesting different causes and potential treatments for these hair loss types.

Finasteride reduces DHT levels and affects gene expression in fish, similar to its effects in humans.

The human type II 5α-reductase gene, linked to certain male health conditions, has a specific structure and low similarity to other related genes.

A gene mutation in Lama3 is linked to a common type of hair loss.

The TRPV3 gene mutation affects hair growth by keeping mice in the growth phase longer, which could help treat hair loss.

A new gene, JMJD1C, may affect testosterone levels in men.

Androgenetic alopecia, or hair loss, is caused by a mix of genetics, hormones, and environment, where testosterone affects hair growth and causes hair to become smaller and grow for a shorter time.

Increased PPARGC1α relates to hair thinning in common baldness.

Six new risk spots for early hair loss were found, which also link to Parkinson's disease and lower fertility. Two genes, FOXA2 and HDAC4, could be new treatment targets. Hair loss might also be connected to heart disease, metabolic syndrome, and prostate cancer.

Melanoma risk tools need improvement, certain gene mutations cause skin diseases and could be treated by targeting those mutations, skin wrinkling may relate to lung aging due to genetic factors, and oxidative stress affects hair loss but can be reduced in low oxygen.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

The Ar/miR-221/IGF-1 pathway is involved in male pattern baldness, with miR-221 potentially being a new target for treatment.

Male genital development is driven by androgen signaling and understanding it could help address congenital anomalies.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.